180 Life Sciences Corp. financial data

Symbol
ATNF, ATNFW on Nasdaq
Industry
Pharmaceutical Preparations
Location
3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
KBL MERGER CORP. IV (to 11/6/2020)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 46.4 % -52.6%
Debt-to-equity 933 % +731%
Return On Equity -559 % +13.4%
Return On Assets -54.1 % +82.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.98M shares -73.6%
Common Stock, Shares, Outstanding 1.03M shares -84.8%
Entity Public Float 5.85M USD -76.9%
Common Stock, Value, Issued 103 USD -84.7%
Weighted Average Number of Shares Outstanding, Basic 981K shares +134%
Weighted Average Number of Shares Outstanding, Diluted 981K shares +134%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 252K USD -74.1%
General and Administrative Expense 576K USD -76.3%
Operating Income (Loss) -6.37M USD +63.9%
Nonoperating Income (Expense) 3.24M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.13M USD +92.9%
Income Tax Expense (Benefit) -2.35M USD
Net Income (Loss) Attributable to Parent -3.12M USD +92.3%
Earnings Per Share, Basic -0.85 USD/shares +96.5%
Earnings Per Share, Diluted 59.5 USD/shares +96.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 53.2M USD
Assets, Current 1.23M USD -63.6%
Intangible Assets, Net (Excluding Goodwill) 9.24M USD +482%
Goodwill 0 USD
Assets 10.5M USD +111%
Accounts Payable, Current 2.09M USD +22%
Accrued Liabilities, Current 466K USD -80.4%
Liabilities, Current 6.38M USD +32.8%
Deferred Income Tax Liabilities, Net 342K USD +22.8%
Liabilities 6.74M USD +31.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.98M USD -4.71%
Retained Earnings (Accumulated Deficit) -129M USD -2.48%
Stockholders' Equity Attributable to Parent 3.73M USD
Liabilities and Equity 10.5M USD +111%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.03M USD +73.3%
Net Cash Provided by (Used in) Financing Activities -264K USD +43.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.03M shares -84.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +69.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 195K USD -92.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1K USD +66.2%
Deferred Tax Assets, Valuation Allowance 18.7M USD +24.3%
Deferred Tax Assets, Gross 19.3M USD +23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.26M USD +91.8%
Deferred Income Tax Expense (Benefit) 2.3M USD
Deferred Tax Assets, Operating Loss Carryforwards 16.5M USD +22.8%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 136M USD +5.54%
Amortization of Intangible Assets 23.6K USD +8.29%
Share-based Payment Arrangement, Expense 16.5K USD -97.4%
Interest Expense 49.7K USD +326%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%